rs28937285
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PP3PP4_ModeratePS3PS4PM2_SupportingPP1_Moderate
This summary comes from the ClinGen Evidence Repository: The c.2215G>A (p.Glu739Lys) missense variant is absent from males in both gnomAD v2.1.1 and v3.1.1, meeting the PM2_Supporting criteria. The variant has a REVEL score of 0.614 (>0.6), meeting PP3 criteria. At least 13 patients with mild hemophilia A are reported in the literature and internal laboratory data meeting F8 phenotype criteria (PMID:24452774, 23711237, 21166991, 8547094, 16972227), which meets the PS4_Very strong and PP4_Moderate criteria. This variant has been labeled as an inverse discrepant variant, where the one-stage assays show lower factor VIII levels than the two-stage, or chromogenic, assays (EAHAD database; PMID:32232366). There were multiple related individuals across 6 different families reported that were genotyped, but their specific relation was not stated, so the PP1 was capped at the moderate weight to be conservative (PMID:24452774). In-vitro assays in COS-1 cells show FVIII-Glu739Lys results in lower FVIII:C in the mild range, as observed in patients with this variant and hemophilia A (PMID:30997536). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS4_Very strong, PS3, PP1_Moderate, PP4_Moderate, PP3, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA255139/MONDO:0010602/071
Frequency
Consequence
ENST00000360256.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F8 | NM_000132.4 | c.2215G>A | p.Glu739Lys | missense_variant | 14/26 | ENST00000360256.9 | NP_000123.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.2215G>A | p.Glu739Lys | missense_variant | 14/26 | 1 | NM_000132.4 | ENSP00000353393 | P1 | |
F8 | ENST00000647125.1 | c.*1881G>A | 3_prime_UTR_variant, NMD_transcript_variant | 14/14 | ENSP00000496062 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111967Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34151
GnomAD4 exome AF: 0.00000547 AC: 6AN: 1097333Hom.: 0 Cov.: 32 AF XY: 0.00000827 AC XY: 3AN XY: 362753
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111967Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34151
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:2
Pathogenic, reviewed by expert panel | curation | ClinGen Coagulation Factor Deficiency Variant Curation Expert Panel, Clingen | Feb 02, 2024 | The c.2215G>A (p.Glu739Lys) missense variant is absent from males in both gnomAD v2.1.1 and v3.1.1, meeting the PM2_Supporting criteria. The variant has a REVEL score of 0.614 (>0.6), meeting PP3 criteria. At least 13 patients with mild hemophilia A are reported in the literature and internal laboratory data meeting F8 phenotype criteria (PMID: 24452774, 23711237, 21166991, 8547094, 16972227), which meets the PS4_Very strong and PP4_Moderate criteria. This variant has been labeled as an inverse discrepant variant, where the one-stage assays show lower factor VIII levels than the two-stage, or chromogenic, assays (EAHAD database; PMID: 32232366). There were multiple related individuals across 6 different families reported that were genotyped, but their specific relation was not stated, so the PP1 was capped at the moderate weight to be conservative (PMID: 24452774). In-vitro assays in COS-1 cells show FVIII-Glu739Lys results in lower FVIII:C in the mild range, as observed in patients with this variant and hemophilia A (PMID: 30997536). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F8: PS4_Very strong, PS3, PP1_Moderate, PP4_Moderate, PP3, PM2_Supporting. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1995 | - - |
F8-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 03, 2024 | The F8 c.2215G>A variant is predicted to result in the amino acid substitution p.Glu739Lys. This variant (aka. p.Glu720Lys) has been reported in multiple individuals with hemophilia A (Schwaab et al. 1995. PubMed ID: 8547094; Factor VIII (F8) Gene Variant Database: https://www.factorviii-db.org/index.php). This variant is reported in 0.0092% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at